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Each day, antibiotic resistance affects the livelihood of individuals worldwide, especially 
in relation to hospital-acquired diseases. In an effort to combat this resistance, antimicrobial 
peptides, small biopolymers produced naturally by multicellular organisms, can be used to 
selectively eliminate bacteria and have demonstrated great potential as alternatives to 
conventional antibiotics. Many naturally-occurring antimicrobial peptides possess high 
concentrations of lysine and arginine amino acid residues, which are protonated and positively-
charged at physiological pH. Herein, we describe the design and synthesis of antimicrobial 
peptide mimics, using amino acid mimics. N-3-aminopropyl methacrylamide (APMA) and 3-
guanidinopropyl methacrylamide (GPMA) monomers mimic the amino acid residues lysine and 
arginine, respectively. Statistical copolymers of these two monomers were synthesized via 
aqueous reversible addition-fragmentation chain transfer (RAFT) polymerization and exhibited 
antimicrobial activity and low eukaryotic cell toxicity. To further analyze the mode of activity of 
these antimicrobial peptide mimics, large unilamellar vesicles (LUVs) containing fluorescent dye 
were prepared in an attempt to study the mechanisms of copolymer interactions with bacteria. . 
Developing a greater understanding of the relationship between the structure of synthetic 
antimicrobial peptide mimics and their respective mode of antimicrobial activity will aid in the 
design of tailored systems to target specific bacterial species. 
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Chapter I:  Introduction 
 
1.1 Prevalence of Antibiotic-Resistant Organisms 
 
 Over the past several decades, the increasing number of microorganisms resistant to 
traditional antibiotics has caused a growing concern for the well-being of individuals worldwide. 
A few examples of resistant bacteria include methicillin-resistant Staphylococcus aureus 
(MRSA), Streptococcus pneumoniae, and multidrug-resistant tuberculosis (MDR TB). The 
presence of resistant strains of bacteria leads to increased healthcare costs for possible treatments 
and an increase in the mortality rate of infected individuals. The amount of drug resistance can 
be attributed, at least in part, to the overuse of widely-available traditional antibiotics, which 
inadvertently promotes the presence of resistant pathogens and adaptive mutations.
1
 In an effort 
to circumvent these and other severe bacterial infections, researchers have sought to exploit the 
benefits of naturally-occurring, antimicrobial peptides.
2-6











Antimicrobial peptides (AMPs) are biological polymers, typically 20 to 50 amino acids in 
length, found in a variety of multicellular organisms. AMPs selectively target bacterial cells and 
induce cell death without causing harm to eukaryotic cells within a certain therapeutic 
concentration range.
7
 Because of the high concentrations of basic amino acids, such as lysine and 
arginine, found in these peptides, AMPs are generally positively-charged at physiological pH 
(Figure 1). Initial interactions between AMPs and bacteria are facilitated via electrostatic 
attraction due to the abundance of negatively-charged phospholipids in the cytoplasmic 
membrane of bacteria. In addition to these hydrophilic residues, AMPs also possess hydrophobic 





way of membrane disruption. In order for bacteria to develop resistance to these peptides, a 




Figure 1. Structures of cationic amino acids lysine (A) and arginine (B), which are protonated at 
physiological pH (~7.4). 
 
Although bacteria share similar structural features, varying membrane compositions can 
lead to differences in therapeutic susceptibility. Thus, certain bacterial species may be vulnerable 
only to particular AMPs or synthetic derivatives.
8
 Differences in vulnerability could be the result 
of the various modes in which the therapeutic agents induce cell death. Unfortunately, the 
mechanisms driving the activity of AMPs are quite complex and not fully understood due to the 
plethora of AMP structures, host biological composition, and other not-well defined variables.
7
 
This research project aims to develop a better understanding of the factors that may affect the 
antimicrobial activity of AMPs by designing structures that mimic naturally, occurring AMPs 








Chapter II: Literature Review of Antimicrobial Peptides and Synthetic Mimics 
 
2.1 Antimicrobial Peptides 
 
Antimicrobial peptides (AMPs) exhibit selective targeting and elimination of bacterial 
species over eukaryotic tissues. The preferred selection of prokaryotes is governed by 
electrostatic attraction between AMPs and bacterial cytoplasmic membranes at physiological pH 
(~7.4 ).
7
 AMPs possess high concentrations of the basic amino acids lysine and arginine, which 
are protonated and positively-charged at physiological pH. The outermost leaflet of prokaryotic 
cytoplasmic membranes is composed of negatively-charged phospholipid head groups, such as 
phosphatidylglycerol, cardiolipin, and phosphatidylserine.
8
 The electrostatic interactions between 
positively-charged AMPs and negatively-charged prokaryotic cell membranes mediate the initial, 
rapid targeting of the bacterial species. The speed at which this interaction occurs must be 
relatively fast in order to avoid renal excretion of the AMPs.
9
 Eukaryotic cell membranes, on the 
other hand, are populated with a majority of zwitterionic phospholipids, such as 
phosphatidylethanolamine, phosphatidylcholine, and sphingomyelin. Since they exhibit a net 
neutral charge, eukaryotic cells are less likely to be targeted by AMPs due to the limited 
electrostatic attraction.
8
 Cholesterol found in the lipid bilayer of eukaryotic membranes is also 
believed to either enhance the stability of the bilayer to AMP infiltration or aid in the 
deactivation of the AMP molecule before membrane disruption can occur.
10
  
AMPs consist of approximately 50% hydrophobic residues, and their hydrophobic 
character is essential for inducing cell death. After the peptide is attracted to a phospholipid 





integrity of the membrane to be compromised.
11
 A schematic representation of one accepted 
mechanism for this process, known as membrane disruption, is depicted in Figure 2. Studies
12-4 
have shown that the selectivity of antimicrobial polymers towards prokaryotic cells over 
eukaryotic cells decreases with increases in available hydrophobic interactions. Thus, if the 
hydrophobicity of the compound is increased past a critical concentration, mammalian cell death 
will dramatically increase despite the presence of zwitterionic phospholipids and other 
compounds in the membrane. These studies
12-4
 suggest that an amphipathic balance of 
hydrophilicity and hydrophobicity must be maintained to minimize eukaryotic cell toxicity while 
maximizing antimicrobial efficiency. 
 
 
Figure 2. The barrel-stave model of the AMPs biocidal mechanism. Modified from Brogden et 
al.
13








An alternative proposed mechanism of antimicrobial action involves AMPs permeation 
of the cell membrane of bacteria and binding to the negatively-charged nucleic acids in the cell, 
which leads to the inhibition of protein synthesis.
15
 Because AMPs interact with the phospholipid 
bilayer of the cytoplasmic membrane, bacterial cells are less likely to develop resistance to 
AMPs than to other conventional antibiotics that may only inhibit pathways that can develop 
resistance easily through mutations.
8
 A drastic change to the membrane composition is highly 
unlikely, which contributes to the difficulty in developing resistance.
8
 However, a limited 
number of organisms have been shown to develop resistance to naturally-occurring AMPs by 
altering the net charge of their outer surface, manipulating the proteins found in the membrane, 
and expressing genes for the production of proteolytic enzymes to degrade AMPs.
13
  
Despite the specificity and therapeutic advantages of AMPs over conventional 
antibiotics, there are several disadvantages of using AMPs. Even though various multi-cellular 
organisms produce AMPs naturally, extraction procedures typically exhibit low yield. 
Furthermore, AMPs can be synthesized from individual amino acids; however, the production 




2.2 Synthetic Antimicrobial Peptide Mimics 
 
 To compensate for the relatively low abundance and costly direct synthesis of AMPs, 
researchers have since attempted to find alternative routes of creating AMP mimics using 










Utilizing ring opening metathesis polymerization (ROMP) with polynorbornene 
derivatives, Ilker et al.
4
 sought to mimic AMPs by forming homopolymers containing a pendant 
primary amine, characteristic of the amino acid lysine, shown in Figure 3. The protonated form 
of this pendant moiety mediates the binding of the polymers to the anionic phospholipid-rich 
surface of prokaryotic cells. Variation in relative hydrophobicity was obtained by changing the 
alkyl chain length and structure as shown in Figure 3 A-D.  Antimicrobial studies showed 
polymer A, which had the least amount of hydrophobic character, was ineffective at eliminating 
bacteria. By increasing the hydrophobicity of the polymers, a general trend of increased 
antimicrobial activity and decreased selectivity was observed. Thus, Ilker and coworkers were 
able to manipulate the amphiphilic balance of the polymers using monomers with desired 
properties at various ratios to synthesize statistical copolymers.
4
 These polymers were found to 
induce prokaryotic cell death via a membrane disruption mechanism. The initial binding to the 
prokaryote was believed to be facilitated by the electrostatic interactions between the cationic 





of the polymers interacted with the hydrophobic core of the phospholipid bilayer, causing the 
cell to rupture. 
 




In previous studies in our laboratories (Paslay et al.
14
), we designed statistical copolymers 
via aqueous reversible addition-fragmentation chain-transfer (RAFT) polymerization using 
monomers with lysine-mimicking residues. The relative hydrophobic character of the monomers 
was altered by incorporating two methyl and two ethyl groups, respectively, as part of the 
pendant amine, as shown in Figure 4. Paslay et al. hypothesized that increasing the 
hydrophobicity would increase membrane activity towards bacteria, while the fully water-soluble 
nature of the amine species would reduce eukaryotic cell toxicity.  While all the polymers 
displayed minimal eukaryotic toxicity, copolymers containing high concentrations of primary 
amine showed the highest levels of toxicity to both Gram-positive and Gram-negative bacteria.
14
 
   Gabriel et al.
3
 explored the possibility of incorporating a guanidinium moiety to alter the 
mode of cell death. The primary amine of polymer A, shown in Figure 3, was substituted with a 
guanidinium moiety, shown in Figure 5A, which mimics the amino acid arginine.
3
 Peptides rich 
in arginine have been shown to present cell penetrating behavior. There has been much research 







Upon internalization, this type of peptide has been shown to bind to negatively-charged nucleic 
acids and inhibit protein synthesis. These and other disruptions in cellular processes promote the 
inability of the cell to sustain life.
15
 While polymer A was ineffective in killing bacteria, upon the 
replacement of the primary amine with the guanidinium moiety for polymer A, Gabriel and 
coworkers showed that the polymer had selective antimicrobial activity without causing any 






Figure 5. Polymer A
4











 evaluated the effect of charge density on selectivity for synthetic AMP 
polynorbornene derivatives.  Polymer C, shown in Figure 3, was modified by increasing the 
number of pendant primary amines from 1 to 3, as shown in Figure 5B. These systems showed a 
decrease in the hemolytic concentration (HC50), or the minimum concentration required for 50% 
hemolysis of blood cells, changing from very hemolytic to (<1 μg/mL) to much less hemolytic 





while maintaining the same relative antimicrobial efficiency reported for the original polymer. 
Further studies are needed to determine if there is a maximum amount of charge density where 
no improved selectivity would be observed.  
 
 




In a recent communication, Treat et al.
17
 report the synthesis of guanidinium-containing 
polymers via aqueous RAFT polymerization to mimic cell-penetrating peptides (Figure 6). 3-
guanidinopropyl methacrylamide (GPMA) was copolymerized with N-(2-hydroxypropyl) 
methacrylamide (HPMA) to create block copolymers.  The penetration of these polymers into 
KB cancer cells through endocytosis and non-endocytosis pathways was probed. Only the 
polymers containing the guanidinium moiety in this study were shown to penetrate the cell 
membrane. Polymers deficient in the guanidinium moiety did not penetrate the cell membrane. 
Antimicrobial activity and biocompatibility were not analyzed in this study.  
 The cell penetration behavior of AMPs mimics and the mechanism by which cell death is 
induced are not well understood. Because of the variable nature of bacterial species, prokaryotes 





many other characteristics.  We hypothesize that structural variations in synthetic AMPs mimics, 
including charge density, molecular weight, hydrophobicity, and functional groups, have a direct 
relationship to antimicrobial activity towards bacteria of different structures.  Developing a 
greater understanding of the relationship between AMPs structure and antimicrobial activity for 
bacterial species of different types will ultimately enable the design of systems to target specific 
prokaryotes based upon their structural features.  
 
Chapter III:  Methodology 
 
3.1 Research Goals and Objectives  
 
The purpose of this research is to design novel homopolymers and statistical copolymers 
that mimic antimicrobial peptides and to study their antimicrobial behavior in order to gain a 
better understanding of the relationship between structural components and mode of activity. The 
goals of this project can be outlined by three main objectives: 
1) Evaluation of antimicrobial activity and hemolytic character of synthesized polymers 
to determine the relationship between activity and polymer composition. 
2) Determination of the relationship between structural features of synthesized 
polymers, such as molecular weight and ionic character, and mechanism of activity. 
3) Characterization of the selectivity of various homopolymer and copolymer systems 
towards a broad range of cell types, including Gram-positive bacteria, Gram-negative 






3.2 Synthesis and Characterization of Antimicrobial Peptide Mimics 
 
 Two monomers, N-3-aminopropyl methacrylamide (APMA) and 3-guanidinopropyl 
methacrylamide (GPMA), were used to create homopolymers and statistical copolymers of 
varying copolymer compositions (Table 1). The nomenclature PGT represents polyGPMA TFA 
and the corresponding number indicates its targeted mole fraction (mol %) in the copolymer.  For 
example PGT 25 represents a copolymer composed of 25 mol % GPMA TFA and 75 mol % 
APMA.  The nomenclature Cl and TFA next to the polymer represent the counterion for APMA 
and GPMA, respectively. 
 
Table 1. Target molecular weight and copolymer composition data for proposed polymer 
systems. 
Polymer Label 
Mol % GPMA 
(theory) 
Mol % APMA 
(theory) 
Mn (g/mol) 
1 (PAPMA) (Cl) 0 100 5,600 
2 (PGT 25) (TFA) 25 75 6,500 
3 (PGT 50) (TFA) 50 50 7,400 
4 (PGT 75) (TFA) 75 25 8,300 
5 (PGT 100) (TFA) 100 0 9,200 
 
APMA consists of a pendant primary amine moiety, similar to the amino acid lysine, and 
was commercially available. GPMA consists of a pendant guanidinium moiety, similar to the 






Figure 7. Structures of N-3-aminopropyl methacrylamide (APMA) and 3-guanidinopropyl 
methacrylamide (GPMA). 
 
 Since GPMA is not commercially available, this monomer was synthesized (Scheme 1). 
In a 250 mL round bottom flask, APMA HCl was dissolved in a mixture of 12 mL DI H2O and 
20 mL (148 mmol) TEA and stirred at 25°C.  10 g (32 mmol) N,N’-di-boc-1H-pyrazole-1-
carboxamidine (PCA) was dissolved in 108 mL acetonitrile and added dropwise to the stirring 
APMA solution via an addition funnel over the course of 30 min.  The reaction progressed for 24 
hours.  The product was obtained via filtration and then washed 3 times with 50 mL DI water 
(yield = 91%).  
In a 250 mL round bottom flask, 10.96 g (28.48 mmol) boc-protected GPMA was 
dissolved in 87 mL CH2Cl2 stirring at 0°C.  87 mL (1.14 mol) (20 equivalences per boc-
protecting group) trifluoroacetic acid (TFA) was then added to the solution dropwise via an 
addition funnel and the reaction was allowed to progress for 16 hours warming from 0°C to 
25°C.  The solvents were removed via rotary evaporation and the resulting clear viscous oil was 
dissolved in 250 mL DI H2O, frozen in liquid N2 and lyophilized for 48 hours.  The product was 
















Scheme 1. Synthesis of GPMA with TFA salt. 
The polymerizations were accomplished via aqueous reversible addition chain transfer 
fragmentation (RAFT) techniques.  Polymer molecular weights were targeted by selecting 
appropriate initial monomer and CTA concentrations.  The ratio of the initial monomer 
concentration (M0) to the initial chain transfer agent concentration (CTA0) was set to be 
approximately 30:1 to yield a degree of polymerization of approximately 30, which mimics the 
size of naturally occurring AMPs.  4-cyano-4-(ethylsulfanylthiocarbonylsulfanyl)pentanoic acid 
(CEP) was used as the CTA and was synthesized via previously published procedures,
18
 while 
4,4’-Azobis(4-cyanopentanoic acid) was used as the initiator.  For all polymerizations, the CTA0 
was five times more than the initial initiator concentration (I0).  The polymerization took place in 
aqueous 2 M acetate buffer (pH 5) at 70 °C
19
 for 6 hours (See Scheme 2). Methanol was added 





reactions were completed the solutions were exposed to air and quenched in liquid nitrogen.  The 
solutions were then dialyzed against water for 72 hours followed by lyophilization for 72 hours 
and the samples were then stored in desiccant.  A representative yield was calculated to be 75% 
of the theoretical yield.  Some polymer is lost in dialysis due to excessive swelling of the dialysis 
tubing as a result of internal osmotic pressure.  This loss can be minimized by making the water 








Scheme 2. Statistical polymerization of APMA with GPMA via aqueous RAFT polymerization. 
 




H) NMR was performed with a Varian Mercury
PLUS
 300 MHz spectrometer in 
deuterated chloroform (CDCl3), utilizing delay times of 5 s to determine monomer purity.  A 500 




C) probe and operating 
at 499.77 MHz (
1
H) was used to confirm the synthesis of the GPMA monomer, identify the 





25, PGT 50, and PGT 75 copolymers in deuterium oxide (D2O).  64 scans were taken for each 
experiment with a 3.1 second recycle delay. 
 
3.2.2 Aqueous Size Exclusion Chromatography 
 
The molecular weight and polydispersity index (PDI) of the polymers were determined 
by aqueous size exclusion chromatography (ASEC) coupled with multi-angle laser light 
scattering (MALLS).  Eprogen CATSEC columns (100, 300 and 1000 Å) were used in 
combination with a Wyatt Optilab DSP interferometric refractometer (k = 690 nm) and a Wyatt 
DAWN DSP MALLS detector (k = 633 nm).  Acetic acid (1 weight %) and 0.1 M sodium 
sulfate (Na2SO4) (aqueous) was used as the eluent at a flow rate of 0.25 mL/min.  The 
interferometric refractometer was utilized off-line to determine dn/dc values for PAPMA at 25 
°C in the eluent (0.2000 mL/g) in order to assign absolute molecular weight values to all 
polymers.  For the statistical polymers the dn/dc values were calculated as the mole fraction-
averaged composites of the measured homopolymer dn/dc values using the copolymer 
compositions determined by NMR spectroscopy.  Wyatt ASTRA size exclusion 











3.3 Quantification of Antimicrobial Activity 
 
3.3.1 Broth Microdilution Method  
 
 Antimicrobial efficiency of the polymers was assessed using Bacillus subtilis (19659), 
Staphylococcus aureus (both Gram-positive bacteria), and Escherichia coli (DH5 α) (Gram-
negative bacteria) following a modified version of a previously published procedure.
3
 Stock 
solutions of both bacterial species were grown at 37°C in inoculated Luria broths (LB) overnight 
while undergoing agitation. Concentrations of 4 to 6 mg/mL polymer stock solutions were 
prepared in tris(hydroxymethyl)aminomethane (TRIS) buffered saline (TBS) (10 mM TRIS, 150 
mM NaCl) (pH 7.4). In a 96 well plate, varying buffered polymer dilutions were mixed 1:1 with 
bacterial cultures that have been diluted with fresh LB to an optical density (OD) of 0.001 at 600 
nm (OD600). Over a 24-hour period, these mixtures were incubated at 37°C with agitation. The 
OD600 was determined using to a UV-Visible plate reader after incubations. Minimum inhibitory 
concentrations (MIC) were reported at multiple time intervals as the polymer concentrations that 
inhibit 90% of bacterial growth. 
 
3.3.2 Agar Plate Conformation of MIC  
 
 To confirm the MIC measurements from the broth microdilution experiments, the 
polymer concentrations above and below the MIC were inoculated with the respective bacterial 
species (B. subtilis, S. aureus, or E. coli) for 24 hours at 37°C with agitation. Inoculums were 





any prevailing bacterial growth. If any living bacteria remained after incubation, bacterial 
colonies were visible on the agar plates. The absence of bacterial growth at the respective 
polymer concentrations confirmed the previously determined MIC.  
 
3.4 Assessment of Eukaryotic Biocompatibility 
 
3.4.1 Hemolysis Studies 
 
Hemolysis experiments were performed according to a modified version of a previously 
published procedure.
4
 Red blood cells (RBCs) were separated from whole human blood by 
centrifugation at 1500 rpm for 10 minutes. RBCs (30 μL) were suspended in 10 mL of buffer 
(TBS at a pH of 7.4), rinsed 3 times by centrifugation (10 min at 1500 rpm) and then re-
suspended in 10 mL TBS.  Polymers were dissolved in TBS to create 6.0 mg/mL stock solutions.  
These solutions were diluted to 0.1, 0.2, 2.0, 4.0 and 6.0 mg/mL.  RBC suspensions were 
incubated 1:1 at 37 °C with light agitation for 30 min with polymer dilutions in microcentrifuge 
tubes to obtain final polymer concentrations of 0.05, 0.1, 1.0, 2.0 and 3.0 mg/mL.  After 
incubation, the tubes were centrifuged at 1500 rpm for 10 min.  The supernatant from each tube 
was transferred to individual wells in a 96 well plate and the absorbance was measured at 540 
nm.  Positive and negative controls for 100 and 0% hemolysis were obtained with 1% Triton-X 








3.4.2 MTT Assay (Cell Viability) 
 
Methyl thiazol tetrazolium (MTT) assay were performed with MCF-7 cell lines using a 
modified version of a previously published procedure.
20
 Cells were cultured on tissue culture 
polystyrene flacon flasks in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 
10% fetal calf serum and 1% antibiotic solution (penicillin and streptomycin) at 37 °C in a 5% 
CO2 incubator.  After obtaining approximately 80% confluence the cells were trypsinized and 
counted on a hemocytometer.  The cells in fresh media were placed into a 96 well plate (8x10
3
 
cells/well) and incubated for 24 hours at 37 °C in a 5% CO2 incubator.  Next, the media was 
removed from each well and 100 μL of fresh media was added.  To select wells (in triplicate) 50 
μL of polymer solutions were added at various concentrations (90, 225, 375, and 6000 μg/mL).  
The resulting solutions had final polymer concentrations of 30, 75, 125, and 2000 μg/mL, 
respectively.  For a positive control, 50 μL TBS (pH 7.4) was used, while 50 μL 3% Triton-X 
was used as a negative control.  Reported data was normalized for viability observed in the 
positive control (taken as 100% viability).  The plate was incubated for 6 or 12 hours at 37 °C in 
a 5% CO2 incubator.  After incubation, the media was removed from each well and 100 μL of 
fresh media was added.  Next, 10 μL of MTT reagent (MTT dissolved in TBS at 5 mg/mL 
concentration) was added to each well and samples were incubated for an additional 4 hours.  
The media from each well was then removed and replaced with 100 μL of DMSO to solubilize 
the formed formazan crystals.  Absorbance readings at 570 nm were recorded using a UV-







3.5 Determination of Prevailing Mode of Activity 
 
 Large unilamellar vesicles (LUVs) were prepared according to a modified version of a 
previously published procedure to determine mode of polymer activity.
3
 A solution of 
zwitterionic lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-ethanolamine (POPE) (3.42 mg, 
0.0045 mmol) and the anionic lipids 1-palmitoyl-2-oleoyl-phosphatidylglycerol (POPG) (1.15 
mg, 0.0015 mmol) were mixed in a 3:1 ratio with 10 mL of chloroform in a 50 mL round-bottom 
flask, mimicking the composition of bacterial cell membranes. The solvent was removed at room 
temperature using a rotary evaporator to form a uniform film in the round-bottom flask. To 
remove any residual solvent, the flask was placed under vacuum for an additional 8 hours. A 40 
mM calcein solution (aqueous) was prepared using a buffer (TBS at a pH of 7.4) as the solvent. 
The calcein dye solution was adjusted to an approximate pH of 7. The dry lipid film was then 
hydrated with 1.5 mL of the 40 mM calcein solution. The lipid and calcein mixture was 
subjected to five freeze/thaw cycles (5 minutes each) using liquid nitrogen and warm water, 
consecutively. Two stacked 200 nm porous polycarbonate membranes were heated to 40°C 
before the entire volume of the mixture was subjected to extrusion for a total of 20 passes 
(Figure 8). The mixture was then removed from the extrusion apparatus and allowed to 
equilibrate to room temperature before being passed through a Sephadex-25 column to remove 
residual calcein dye. Fractions of approximately 5 drops each were collected in Eppendorf 












After the collection of the fractions, the hydrodynamic radius of the artificial vesicles was 
analyzed and confirmed to be 200 nm using dynamic light scattering. UV-Vis spectroscopy was 
used to determine the proper vesicle concentration to use for the LUV experiments. For this, 0.4 
weight % Triton-X was added to the vesicle solution and the vesicle dilution for which the 
absorbance was less than 0.01 absorbance units for the UV-Vis experiment was recorded and 
used for the subsequent LUV studies. The average MIC of polymers (70 µg/mL) was used as the 
respective polymer concentration for the LUV studies. The percentage dye leakage was recorded 
as a function of time with a fluorometer after allowing 1 minute for the system to equilibrate per 
sample. The amount of dye released from the LUVs was evaluated to determine the mechanism 
of cell death, with a large release amount indicating cell death via a membrane disruption 
mechanism, while a small release amount indicates a membrane penetration mechanism of action 









Chapter IV: Results and Discussion 
 
4.1 Monomer and Polymer Characterization 
 
As described in detail previously, the NMR spectra were collected for the boc-protected GPMA 
(Figure 9) and the final boc-deprotected GPMA salt (Figure 10). Most notable in Figure 9 is the 
presence of the tert-butyl ester protecting group (~1.5 ppm) from the reaction with PCA. Upon 
deprotection with TFA, the signal peak at ~1.5 ppm disappears and the amine protons of the guanidinium 













H NMR spectrum of GPMA after boc-deprotection with TFA. 
 
During the aqueous RAFT polymerization process, the reaction progress of APMA-stat-
GPMA was monitored by taking aliquots every hour from the PGT 50 reaction vial.  
1
H NMR 
was utilized to determine the monomer concentration [M] at time (t) by comparing the vinylic 
hydrogen peak integrations to the integration of an internal standard, methanol (MeOH).  A plot 
of ln([M0]/[M]) versus time indicates that the reaction follows linear pseudo first-order reaction 






Figure 11. APMA-stat-GPMA reaction kinetics. ln([M0]/[M]) versus time kinetic plot for the 
polymerization of 1:1 molar ratio of APMA:GPMA TFA. The linear relationship indicates that 
the polymerization follows a predictable first-order reaction behavior typical of aqueous RAFT 
polymerizations. 
 
Aqueous size exclusion chromatography (ASEC) coupled with multi-angle laser light 
scattering (MALLS) was utilized to monitor molecular weight as a function of time.  The 
refractive index (RI) response versus elution volume for aliquots taken at each time interval is 
shown in Figure 13. As shown in this graph, the polymer molecular weight increases over time. 
The narrowing of the peak is indicative of a narrowing PDI over time. 
 
y = 0.0062x - 0.038 























Figure 12. APMA-stat-GPMA molecular weight distribution as a function of reaction time. RI 
response versus elution volume at multiple time intervals during the polymerization reaction. 
 
For each of the polymers, unique peak assignments were made, and the copolymer 
compositions were calculated for the statistical polymers via peak integration (Figure 13). A 

























Figure 13. Representative 
1
H NMR spectrum of APMA-stat-GPMA copolymer. The target 
APMA/GPMA composition for the above formulation was 50:50 mol %.  Peak integration 
indicates 45 mol % GPMA in the copolymer. 
 
























1 (PAPMA) (Cl) 0 0 5,600 6,500 1.06 0.200 
2 (PGT 25) (TFA) 25 23 6,500 6,900 1.03 0.183 
3 (PGT 50) (TFA) 50 45 7,400 6,100 1.06 0.169 
4 (PGT 75) (TFA) 75 72 8,300 5,800 1.12 0.152 



















4.2 Antimicrobial Behavior 
 
 The minimum inhibitory concentrations (MIC) were determined for each polymer for 
each of the three bacteria types (B. subtilis, S. aureus, and E. coli). The findings of these 
experiments are summarized in Table 3. 
 
Table 3. Summary of broth microdilution testing of various polymers with bacteria as 
determined through optical density measurements. 










 E. coli (DH5 α)
c
 
1 (PAPMA) (Cl) < 25 ~ 300 ≥ 300 
2 (PGT 25) (TFA) < 25 ~ 300 70 - 300 
3 (PGT 50) (TFA) < 25 ~ 300 70 - 300 
4 (PGT 75) (TFA) < 25 ~ 300 ~ 70 
5 (PGT 100) (TFA) < 25 ~ 300 ~ 70 
a
Determined by broth microdilution testing.  
b
Gram (+) bacteria. 
c
Gram (-) bacteria. 
 
 To validate the MIC measurements obtained from the broth microdilution testing, the 
polymer concentrations above and below the MIC were inoculated with the respective bacterial 
species (B. subtilis, S. aureus, or E. coli), streaked onto agar plates and allowed to grow. As 
shown in Figure 14, the inoculums grown on the agar plates confirmed the MIC values obtained 









(iii) E. coli 
PAPMA PGT 25 




(i) B. subtilis (ii) S. aureus 
PAPMA PAPMA PGT 25 PGT 25 
PGT 50 PGT 50 
PGT 75 
PGT 75 
PGT 100 PGT 100 
 
Figure 14. MIC agar plate confirmation. All 
agar plates consisted of a negative control (-) 
where only bacteria and no polymers were 
present along with a positive control (+) where 
only polymers and no bacteria were present. (i) 
B. subtilis with polymer concentration ranges of 
25 (B), 50 (C), 70 (D), and 80 (E) µg/mL. (ii) S. 
aureus with polymer concentration ranges of 70 
(A), 150 (B), 230 (C), and 300 (D) µg/mL. (iii) 
E. coli with polymer concentration ranges of 70 





4.3 Hemolysis Studies 
 
 An effective way to test eukaryotic cell toxicity is to study the hemolytic behavior of a 
system.  While not conclusive, hemolysis experiments are used to indicate the possibility of 
eukaryotic cell toxicity. Less than 10 % hemolysis was observed for all polymer types, even at 
high concentrations (3,000 µg/mL). With increasing polymer concentration the percentage of red 
blood cells that lyse should either remain the same or increase, and within experimental error (as 









Figure 15. Polymers cause negligible hemolysis (<10 %) up to 3000 μg/mL. The concentration 
of polymer required to cause 50 % hemolysis (HC50) is reported as >3000 μg/mL to estimate 









4.4 MTT Assay (Cell Viability) 
 
 MTT assays were performed to further investigate the eukaryotic cytotoxicity of the 
homopolymers of APMA and GPMA and the statistical copolymer PGT 50. Figure 16 shows 
cell viability as a function of polymer concentration after 6 and 12 hours for these polymers. In a 
MTT assay, the conversion of MTT to purple formazan by mitochondrial reductase is utilized to 
quantify the mitochondrial activity of the cells rather than directly visualizing the number of 
living cells. Although the homopolymer of GPMA (PGT 100) caused negligible hemolysis, a 
drastic reduction in MCF-7 cell viability was observed at high concentrations (>200 µg/mL). 
However, this concentration is much higher than that required for antimicrobial effectiveness,  











Figure 16. Cell viability of MCF-7 cells after incubation with polymers PAPMA (bottom left), 



















Polymer Concentration (µg/mL) 
PGT 100  



















Polymer Concentration (µg/mL) 
PAPMA 



















Polymer Concentration (µg/mL) 
PGT 50 





Chapter V: Conclusions  
 
 A series of well-defined primary amine-functionalized and guanidinium-functionalized 
methacrylamide homopolymers and statistical copolymers were synthesized via aqueous RAFT 
polymerization. These polymeric mimics of antimicrobial peptides were all shown to exhibit 
excellent antimicrobial behavior (MICs of ~300 µg/mL or lower) for B. subtilis, S. aureus, and 
E. coli. With B. subtilis and S. aureus, the MICs of the AMP mimics appeared to be the same for 
all polymer types of the respective bacteria. However with E. coli, increasing the guanidinium 
content greatly enhanced the antimicrobial efficiency of the polymer. Thus, the polymer 
structure, such as the presence of a primary amine and/or guanidinium moiety, appears to play a 
crucial role in its antimicrobial activity. 
  As shown in the biocompatibility studies (hemolysis experiments and MTT assays), 
these AMP mimics were shown to be selective for bacterial cells within the respective 
therapeutic range. However, the homopolymer of GPMA (PGT 100) was shown to drastically 
reduce cell viability at relativity high concentrations (>200 µg/mL). This trend, which did not 
appear in the cell viability trends of PAPMA or PGT 50, is most likely the result of a change in 
the mechanism of activity. Copolymers with high concentrations of guanidinium have been 
previously shown to follow a primarily membrane permeation mechanism, and this would 
explain the increased antimicrobial behavior and decreased cell viability at high concentrations.
22
 
At high concentrations of the guanidinium moiety, loss of selectivity may occur due to the 
change in the mechanism of activity. 
 After several attempts to perform the large unilamellar vesicles (LUV) studies, the data 





LUVs along with a high degree of experimental error yielded no reproducible data.  Because 
negligible hemolysis was observed for all polymer compositions, it is concluded that the cell 
permeation mechanism was the dominant mode of antimicrobial activity for the polymers tested.  
Further investigation, including LUV experiments, is needed to substantiate this claim. 
 
Chapter VI: Future Work 
 
 Antimicrobial peptide (AMP) mimics have been shown to be a promising alternative for 
conventional antibiotics against antibiotic-resistant microbes. It is recommended that LUV 
studies be performed with the antimicrobial peptide mimics described in this study. Elucidating 
the mechanism of action of these polymers will help to provide a better understanding of the 
structure-activity relationships present in these compounds. Once a suggested mechanism of 
action is proposed from the LUV studies, transmission electron microscopy imaging should be 
performed to further validate the proposed mechanism of action. This knowledge will be 
beneficial in designing new antimicrobial peptide mimics to target specific antibiotic-resistant 
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